Home
Home

Prolia

5 Drug Hopefuls That Are Going to Change Your Life: Part 3

5 Drug Hopefuls That Are Going to Change Your Life: Part 3
Motley Fool

Another Approval for Amgen's Prolia

Another Approval for Amgen's Prolia
Yahoo/Zacks

Anemic Growth? Not From These Drugs.

Anemic Growth? Not From These Drugs.
Motley Fool

Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial

Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
Yahoo/PR NewsWire

Amgen Wins Expanded U.S. Approval for Bone-Strengthening Drug

Amgen Wins Expanded U.S. Approval for Bone-Strengthening Drug
Bloomberg

Long-Term Data on Amgen's Prolia

Long-Term Data on Amgen's Prolia
Yahoo/Zacks.com

News

Amgen Exec: “Clearly Superior” Prostate Cancer Drug Will Be Huge
Forbes

News

One Drug, Two Names, Two Wildly Different Prospects
Motley Fool

News

Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Bradenton Herald, FL

News

Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency
Bloomberg
»